{"DataElement":{"publicId":"7429193","version":"1","preferredName":"Timepoint Response","preferredDefinition":"Results of the disease response timepoint assessment based on sponsor defined coded terminology.","longName":"RSORRES_TPTRESP_SPD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7429192","version":"1","preferredName":"Disease Response Domain Timepoint Disease Response Original Result","preferredDefinition":"A domain for disease response evaluations._A specific point in the time continuum, including those established relative to an event._The outcome of the disease response assessment as originally received or collected.","longName":"6608777v1.0:7429190v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7429190","version":"1","preferredName":"Timepoint Disease Response Original Result","preferredDefinition":"A specific point in the time continuum, including those established relative to an event.:The outcome of the disease response assessment as originally received or collected.","longName":"C68568:C117397","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response Original Result","conceptCode":"C117397","definition":"The outcome of the disease response assessment as originally received or collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD968ED-C82F-477F-E053-4EBD850A6598","latestVersionIndicator":"Yes","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD968ED-C840-477F-E053-4EBD850A6598","latestVersionIndicator":"Yes","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"TAYLORT","dateModified":"2020-09-23","changeDescription":"PED-CITN-01 NSV; TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7429189","version":"1","preferredName":"Disease Response Original Result Clinical Study Sponsor Defined Code","preferredDefinition":"The outcome of the disease response assessment as originally received or collected._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]._Clearly characterized or delimited._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"RSORRES_RESP_SPD_CODE","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"iMR","valueDescription":"Immune Minor Response","ValueMeaning":{"publicId":"7429311","version":"1","preferredName":"Immune Minor Response","longName":"7429311","preferredDefinition":"Protected against infectious disease by either specific or non-specific mechanisms.: Some response with no new symptoms or disease and not meeting partial response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Minimal Response","conceptCode":"C123598","definition":"A finding indicating that there is an improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFDA2AF2-D984-20F6-E053-4EBD850AD191","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFDA2AF2-D99F-20F6-E053-4EBD850AD191","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"3284666","version":"1","preferredName":"Progressive Disease","longName":"3284666v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9FC7D6-531D-BE97-E040-BB89AD437875","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2023.5.17 Alt VM added per ticket request CADSR0002435. ak \r\n2023.3.15 Per LS at COG Protocol defined progressive disease (should have been added as a VM Alt Name for PV 3284666). ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFED88A0-2592-1B82-E053-4EBD850A6128","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"Non-iCR/non-iUPD","valueDescription":"Non iRECIST Complete Response-Non iRECIST Unconfirmed Progressive Disease","ValueMeaning":{"publicId":"6059613","version":"1","preferredName":"Non iRECIST Complete Response-Non iRECIST Unconfirmed Progressive Disease","longName":"6059613","preferredDefinition":"Persistence of one or more non-target lesion(s) without unequivocal progression following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non iRECIST Complete Response-Non iRECIST Unconfirmed Progressive Disease","conceptCode":"C142361","definition":"Persistence of one or more non-target lesion(s) without unequivocal progression following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"642A8BA4-5722-6C04-E053-F662850A1959","latestVersionIndicator":"Yes","beginDate":"2018-02-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-02-01","modifiedBy":"ONEDATA","dateModified":"2018-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB21-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"iCPD","valueDescription":"iRECIST Confirmed Progressive Disease","ValueMeaning":{"publicId":"6056545","version":"1","preferredName":"iRECIST Confirmed Progressive Disease","longName":"6056545","preferredDefinition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Confirmed Progressive Disease","conceptCode":"C142356","definition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5AF2-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB2B-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"iUPD","valueDescription":"iRECIST Unconfirmed Progressive Disease","ValueMeaning":{"publicId":"6056543","version":"1","preferredName":"iRECIST Unconfirmed Progressive Disease","longName":"6056543","preferredDefinition":"Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Unconfirmed Progressive Disease","conceptCode":"C142360","definition":"Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5ACC-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB35-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"iSD","valueDescription":"iRECIST Stable Disease","ValueMeaning":{"publicId":"6056539","version":"1","preferredName":"iRECIST Stable Disease","longName":"6056539","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Stable Disease","conceptCode":"C142359","definition":"Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5A80-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB3F-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"iPR","valueDescription":"iRECIST Partial Response","ValueMeaning":{"publicId":"6056541","version":"1","preferredName":"iRECIST Partial Response","longName":"6056541","preferredDefinition":"A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Partial Response","conceptCode":"C142358","definition":"A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5AA6-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB49-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"iCR","valueDescription":"iRECIST Complete Response","ValueMeaning":{"publicId":"6056547","version":"1","preferredName":"iRECIST Complete Response","longName":"6056547","preferredDefinition":"The disappearance of all signs of cancer following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Complete Response","conceptCode":"C142357","definition":"The disappearance of all signs of cancer following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5B18-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB53-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB72-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"MR","valueDescription":"Minor Response","ValueMeaning":{"publicId":"5607583","version":"1","preferredName":"Minor Response","longName":"5607583","preferredDefinition":"A finding indicating that there is an improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimal Response","conceptCode":"C123598","definition":"A finding indicating that there is an improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44053298-D162-7592-E053-F662850AB82F","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"SOKKERL","dateModified":"2023-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB7C-40E6-E053-4EBD850A9FF0","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"CPD","valueDescription":"Progressive Disease, Confirmed","ValueMeaning":{"publicId":"5895898","version":"1","preferredName":"Progressive Disease, Confirmed","longName":"5895898","preferredDefinition":"Having been established or verified.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BAF5DA-7116-75C8-E053-F662850AED93","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-07","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB90-40E6-E053-4EBD850A9FF0","beginDate":"2017-07-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"3951936","version":"1","preferredName":"Complete Remission","longName":"3951936v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5DA-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EB9A-40E6-E053-4EBD850A9FF0","beginDate":"2017-07-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Remission","ValueMeaning":{"publicId":"3854969","version":"1","preferredName":"Partial Remission","longName":"3854969","preferredDefinition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3DF4512-86B4-A83E-E040-BB89AD431C6D","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Manually curated for OHSU 10262.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EBA4-40E6-E053-4EBD850A9FF0","beginDate":"2017-07-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EBAE-40E6-E053-4EBD850A9FF0","beginDate":"2017-07-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"},{"value":"UPD","valueDescription":"Unconfirmed Progressive Disease","ValueMeaning":{"publicId":"5895900","version":"1","preferredName":"Unconfirmed Progressive Disease","longName":"5895900","preferredDefinition":"A disease process that is increasing in scope or severity but the criteria for progressive disease is not met.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unconfirmed Progressive Disease","conceptCode":"C123607","definition":"A disease process that is increasing in scope or severity but the criteria for progressive disease is not met.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BAF5DA-713C-75C8-E053-F662850AED93","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD95BEF-EBC2-40E6-E053-4EBD850A9FF0","beginDate":"2017-07-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"ONEDATA","dateModified":"2020-09-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7429304","version":"1","preferredName":"Disease Response Original Result Clinical Study Sponsor Defined Code","preferredDefinition":"The outcome of the disease response assessment as originally received or collected.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C117397:C70793:C165683:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Original Result","conceptCode":"C117397","definition":"The outcome of the disease response assessment as originally received or collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD8B7BB-F78B-5AC7-E053-4EBD850A7DD8","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD95BEF-EB02-40E6-E053-4EBD850A9FF0","latestVersionIndicator":"Yes","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"TAYLORT","dateModified":"2020-09-23","changeDescription":"PED-CITN-01 NSV; TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"BESTRESP_INRC","type":"OID, Theradex","context":"Theradex"},{"name":"BESTRESP_IR","type":"OID, Theradex","context":"Theradex"},{"name":"RSORRES_IRANORESP","type":"OID, Theradex","context":"Theradex"},{"name":"RSORRES_RECILRESP","type":"OID, Theradex","context":"Theradex"},{"name":"RS_RSORRES_MIBG","type":"OID, COG","context":"COG"}],"ReferenceDocuments":[{"name":"Timepoint Response","type":"Preferred Question Text","description":"Timepoint Response","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"iRANO time point response","url":null,"context":"Theradex"},{"name":"Theradex - 2","type":"Alternate Question Text","description":"RECIL 2017 Timepoint Response","url":null,"context":"Theradex"},{"name":"Theradex - 3","type":"Alternate Question Text","description":"iRECIST Timepoint Response","url":null,"context":"Theradex"},{"name":"Theradex - 4","type":"Alternate Question Text","description":"Adapted Revised INRC timepoint response for MIBG Avid Disease and Measurable soft tissue disease","url":null,"context":"Theradex"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"MIBG Scan Response:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD9A413-5B72-731F-E053-4EBD850ABD3E","latestVersionIndicator":"Yes","beginDate":"2020-09-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-21","modifiedBy":"GDEEN","dateModified":"2023-04-20","changeDescription":"PED-CITN-01 NSV; TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}